3 completed, 1 active not recruiting, 1 terminated, 1 unknown. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow Pediatric Lymphoma: new trials by email Literature Review of Pediatric Lymphoma trials Research Report on Pediatric Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Different Sonographic Modalities and PET-CT in Pediatric Lymphoma ultrasonography - Pediatric Lymphoma | Unknown | Assiut University | 45 | 2022-06-01 | 2022-04-25 | |
| Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors Acute Lymphoblastic Leukemia, Pediatric, Pediatric ALL | Completed | University of Nebraska | 40 | 2020-11-01 | 2024-08-30 | |
| 9-ING-41 in Pediatric Patients With Refractory Malignancies. 9-ING-41, Irinotecan, Temozolomide - Refractory Cancer, Refractory Neoplasm | Phase 1 | Terminated | Actuate Therapeutics Inc. | 40 | 2020-06-05 | 2025-07-17 |
| Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia Intravenous fluids - Lymphoma, Acute Lymphoblastic Leukemia | Phase 1 | Completed | Virginia Commonwealth University | 10 | 2019-10-02 | 2024-02-13 |
| Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas CLR 131 - Pediatric Solid Tumor, Pediatric Lymphoma | Phase 1 | Active not recruiting | Cellectar Biosciences, Inc. | 30 | 2019-04-30 | 2026-10-01 |
| Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients Early palliative care, Routine hospice care - Stage IV Breast Cancer, Stage IV Pancreatic Cancer | Completed | Seoul National University Hospital | 444 | 2016-12-17 | 2021-03-17 |
Lymphoma (3) · Diffuse Intrinsic Pontine Glioma (2) · Neoplasms (2) · Neuroblastoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Bone Diseases, Metabolic (1) · Breast Neoplasms (1) · Colonic Neoplasms (1) · Desmoplastic Small Round Cell Tumor (1) · Ependymoma (1) · Glioblastoma (1) · Glioma (1) · Gliosarcoma (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1)
Hemic and Lymphatic Diseases (4) · Neoplasms by Histologic Type (4) · Hematologic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Site (3) · Brain Diseases (2) · Brain Neoplasms (2) · Brain Stem Neoplasms (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Infratentorial Neoplasms (2)
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (1) · CLR1404 (1) · Cyclophosphamide (1) · Irinotecan (1) · Temozolomide (1) · Topotecan (1) · Ultrasonography (1)
Actuate Therapeutics Inc. (1) · Assiut University (1) · Cellectar Biosciences, Inc. (1) · Seoul National University Hospital (1) · University of Nebraska (1) · Virginia Commonwealth University (1)
United States (4) · Australia (1) · Canada (1) · South Korea (1)
Cady P Noda, PharmD (1) · Jarrod Longcor (1) · Laura D Bilek, PhD (1) · Young Ho Yun, MD-PhD (1)
PMID 24327518, PMID 27424289, PMID 28053024, PMID 28672195, PMID 29383130, PMID 29846250, PMID 31101621, PMID 31533931, PMID 31831767, PMID 31882719, PMID 39582048, PMID 39868759